News
East West Bancorp Q2 Earnings Top on Higher NII & Non-Interest Income
East West Bancorp, Inc.’s EWBC second-quarter 2025 adjusted earnings per share (EPS) of $2.28 beat the Zacks Consensus Estimate of $2.23. Moreover, the bottom line increased 9.1% from the prior-year
Essex Property to Report Q2 Earnings: What to Expect From the Stock?
Essex Property Trust, Inc. ESS is scheduled to report its second-quarter 2025 results on July 29, after market close. The company’s quarterly results are likely to reflect year-over-year growth in
SAP's Q2 Earnings Beat Estimates, Revenues Miss, Stock Falls
SAP SE (SAP) reported second-quarter 2025 non-IFRS earnings of €1.50 ($1.70) per share, climbing 37% from the year-ago quarter’s levels. The Zacks Consensus Estimate was pegged at $1.63.
Driven by
Here's What to Expect From Pfizer's Non-Oncology Drugs in Q2 Earnings
Pfizer PFE is due to report second-quarter results on Aug. 5. All eyes will be on sales of Pfizer’s oncology drugs, which account for around 25% of the company’s total revenues. Pfizer’s key
Pre-Markets Shine on Japanese Auto Trade Deal
Wednesday, July 23, 2025Pre-market futures are up today, led by foreign auto companies — particularly those in Japan. A new trade agreement was announced that lowers tariffs on Japanese imported
Enterprise Suite and Agentic AI: Can Intuit Win Mid-Market?
Intuit Inc. INTU unveiled its newest agentic AI enhancements for Intuit Enterprise Suite this week. The update introduces four AI agents — Finance, Payments, Accounting, Project Management — that
Intuitive Surgical Crushes Q2 Expectations, So Why No Rally?
The world’s second-largest company in the healthcare equipment and supplies industry, Intuitive Surgical (NASDAQ: ISRG), just reported Q2 financials. The results were solid, but not enough to move
Can Organic Asset Expansion Fuel Energy Transfer's Long-Term Growth?
Energy Transfer LP ET is expanding its organic asset base to meet increasing pipeline and storage requirements across the United States. With demand increasing for pipeline capacity, natural gas
NVR (NVR) Q2 Earnings and Revenues Surpass Estimates
NVR (NVR) came out with quarterly earnings of $108.54 per share, beating the Zacks Consensus Estimate of $104.89 per share. This compares to earnings of $120.69 per share a year ago. These figures
First Community (FCCO) Tops Q2 Earnings and Revenue Estimates
First Community (FCCO) came out with quarterly earnings of $0.67 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.42 per share a year ago. These
Thermo Fisher Q2 Earnings & Revenues Beat, Stock Up in Pre-Market
Thermo Fisher Scientific Inc.'s TMO second-quarter 2025 adjusted earnings per share (EPS) of $5.36 beat the Zacks Consensus Estimate by 2.7%. However, the figure decreased 0.2% year over year.
The
Watch These 4 Transportation Stocks for Q2 Earnings: Beat or Miss?
The widely diversified Zacks Transportation sector is currently navigating a challenging macroeconomic environment. The sector grapples with multiple headwinds, ranging from escalated expenses
3 Mortgage & Related Services Stocks to Watch Amid Industry Challenges
The Zacks Mortgage & Related Services industry continues to be hindered by volatility in mortgage rates due to macroeconomic uncertainty. With relatively higher mortgage rates, the purchase
Implied Volatility Surging for Ryan Specialty Holdings Stock Options
Investors in Ryan Specialty Holdings, Inc. RYAN need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 17, 2025 $35.00 Call had some of the
From SpaceX to xAI: How ETFs Are Packaging Private Assets
Last week, The Wall Street Journal reported that the Trump administration is likely to issue an executive order that would open the retirement market to private assets.
Shares of the largest private
Leisure & Recreation Industry Looks Promising: 3 Stocks to Buy
Can Recent Pipeline Expansion Efforts Offset RXRX's Earlier Losses?
Recursion Pharmaceuticals RXRX faced a significant setback in May 2025 after announcing the discontinuation of three key drug candidates — REC-994, REC-2282, and REC-3964 — as part of its broader
Universal Health to Report Q2 Earnings: What Do the Key Estimates Say?
Universal Health Services, Inc. UHS is set to report second-quarter 2025 results on July 28, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is
NextEra Energy Stock: AI Boom Powers Strong Q2 Growth
Florida-based NextEra Energy has significantly outperformed market expectations in the second quarter, posting an adjusted earnings per share of $1.05 versus analyst estimates of $1.01. This
Tourmaline Oil Corp. (TRMLF) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Tourmaline Oil Corp. (TRMLF) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known
Wingstop (WING) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
The market expects Wingstop (WING) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is
Virtu Financial (VIRT) Earnings Expected to Grow: Should You Buy?
Virtu Financial (VIRT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook